COSTA MESA, Calif., Sept. 9, 2021 /PRNewswire/ -- CureClick, the world's first proprietary crowdsourcing platform that matches clinical trials to available patients, today demonstrated its commitment to reshaping the clinical recruitment industry by announcing the appointment of renowned digital health strategist Nico Coetzee to the post of Chief Marketing Officer. Coetzee will guide the team responsible for creating, communicating, and delivering innovative clinical recruitment solutions that drive value for patients and clients, as well as business partners of CureClick.
In recent years, Big Tech has gotten a bad rep. But of course, many tech companies are doing important work making monumental positive changes to society, health, and the environment. To highlight these, we started a new interview series about “Technology Making An Important Positive Social Impact”. We are interviewing leaders of tech companies who are creating or have created a tech product that is helping to make a positive change in people’s lives or the environment. As a part of this series, I had the pleasure of interviewing Fabio Gratton, Co-founder and CEO of inVibe Labs.
In the high-demand, high-service, high-stakes advertising and communications sector of the life-sciences industry, agency executives consistently juggle myriad client priorities, business pressures, and channel opportunities, all the while keeping the creative juices flowing. Some of the industry’s top strategists and creative talents join this month’s Agency Roundtable to raise their voices on what’s hot and what’s not.
Clinical trial recruitment is notoriously difficult. Finding, vetting, qualifying, and managing trial participants is time-consuming and expensive, with numerous obstacles hindering every step of the arduous process. From precise patient identification to compelling behavioral motivation, traditional approaches often fall short and cost pharma companies millions of dollars and months if not years of delays in drug development.
inVibe Labs has adapted many of the sophisticated tools of Big Tech to revolutionize market research for healthcare, including harnessing the power of voice, and in doing so has again joined the ranks of the Inc. 5000 list of fastest-growing private companies. Thanks to filling an ever-growing need for frictionless market research by continuing to innovate and adding more top talent, their three-year growth rate of 371 percent has earned inVibe the rank of #1,295 on the annual list, for the third year in a row.
Big Tech companies have mastered the consumer experience, enabling the likes of Apple, Google, and Amazon to evolve within a few short years from tiny Silicon Valley startups to trillion-dollar market cap behemoths. Through a robust combination of digital profiling, precision targeting, and dynamic engagement, they provide an unprecedented level of personalization, two-way communication, and real-time responsiveness that has transformed all of our lives.
Apple, Microsoft, Amazon, and Google/Alphabet are the first companies to reach market capitalization of over a trillion dollars, with no end in sight for continued exponential growth across the technology sector. At the core of their jaw-dropping success is a revolution in the customer experience, triggered by digital and empowered through data-driven personalization.
Advances in big-data analytics are increasingly being employed to extract targeted information with the potential to drive life-sciences research and clinical practice closer to the goal of personalized and precision medicine.
Irvine-based CureClick and Thread of North Carolina have formed a partnership to improve patient recruitment for clinical trials. CureClick tackles major barriers to clinical trial recruitment, including lack of patient awareness and fear of experimental medication safety, through a community of patient activists and influencers.
As the hype around so-called siteless trials continues unabated, two trial tech firms are joining forces to tap social media influencers to help push more patients into studies. The pair: decentralized clinical research company Thread and trial recruitment firm CureClick. They say their new pact will allow sponsors and contract research organizations to “access the power of patient activist-driven crowdsourcing to improve recruitment” in virtual trials.
Fulfilling a commitment to diversity and inclusion in the Phase 3 COVE Study of the Moderna COVID-19 Vaccine, Moderna enlisted the help of TrialScope, the global leader in clinical trial disclosure and transparency technology, for patient recruitment. Moderna utilized TrialScope Connect, an industry-first patient referral collective that connects sponsors and clinical trial recruitment partners to rapidly find, screen and enroll clinical trial participants.
The Gratton-led Alchemy Factory has hatched a series of its own ground-breaking ventures, including CureClick, a novel crowdsourced clinical trial recruitment service, inVibe, a disruptive speech emotion market research platform for health, SONIC, a story-driven idea consultancy, BryteLife, an electrolyte-charged club soda, and Carma, a real-world game where everyday people can save lives and earn rewards..
Fabio is the founder of Alchemy Factory, a southern California-based digital health incubator and co-work space focused on helping companies accelerate/commercialize products. Previously Fabio founded one of the leading digital agencies in the US, Ignite Health, that went on to be acquired by inVentiv Health in 2007. Fabio stayed on to operate as Chief Innovation Officer through 2013 then left to spend time with family.
At the Gratton residence, Fabio has made a lifetime commitment to providing endless buckets of love for his family. And like most daddies, he has spent the past several years working diligently to crack the code on life/work harmony.